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Abstract
Increased abundance ofGardnerella vaginalis and sialidase activity in vaginal fluid is associ-
ated with bacterial vaginosis (BV), a common but poorly understood clinical entity associated
with poor reproductive health outcomes. Since most women are colonized withG. vaginalis, its
status as a normal member of the vaginal microbiota or pathogen causing BV remains contro-
versial, and numerous classification schemes have been described. Since 2005, sequencing
of the chaperonin-60 universal target (cpn60 UT) has distinguished four subgroups in isolate
collections, clone libraries and deep sequencing datasets. To clarify potential clinical and diag-
nostic significance of cpn60 subgroups, we undertook phenotypic andmolecular characteriza-
tion of 112G. vaginalis isolates from three continents. A total of 36 subgroup A, 33 B, 35 C and
8 D isolates were identified through phylogenetic analysis of cpn60 sequences as correspond-
ing to four “clades” identified in a recently published study, based on sequencing 473 genes
across 17 isolates. cpn60 subgroups were compared with other previously describedmolecular
methods for classification ofGardnerella subgroups, including amplified ribosomal DNA restric-
tion analysis (ARDRA) and real-time PCR assays designed to quantify subgroups in vaginal
samples. Although two ARDRA patterns were observed in isolates, each was observed in
three cpn60 subgroups (A/B/D and B/C/D). Real-time PCR assays corroborated cpn60 sub-
groups overall, but 13 isolates from subgroups A, B and Dwere negative in all assays. A puta-
tive sialidase gene was detected in all subgroup B, C and D isolates, but only in a single sub-
group A isolate. In contrast, sialidase activity was observed in all subgroup B isolates, 3 (9%)
subgroup C isolates and no subgroup A or D isolates. These observations suggest distinct
roles forG. vaginalis subgroups in BV pathogenesis. We conclude that cpn60 UT sequencing
is a robust approach for definingG. vaginalis subgroups within the vaginal microbiome.
Introduction
Gardnerella vaginalis is recognized as a ubiquitous element of the complex of vaginal organ-
isms in healthy women, but is more abundant in women diagnosed with bacterial vaginosis
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(BV), a poorly defined and recalcitrant clinical entity affecting reproductive health [1, 2]. The
phenotypic heterogeneity of G. vaginalis is well known, and several biotyping and genotyping
methods have been developed [3, 4]. For example, amplified ribosomal DNA restriction analy-
sis (ARDRA) was introduced in 1997 [4] and has been applied to classify G. vaginalis into sub-
groups in several studies [5, 6]. More recent sequence-based analyses have demonstrated that
this taxon consists of four distinct molecular subgroups, likely to be different species, based on
473 genes common to 17 G. vaginalis isolates (clades 1–4) [7], or by sequencing a single 552 bp
region of the chaperonin-60 (cpn60) gene (subgroups A-D) [8]. Real-time PCR assays based on
clade-specific genes and designed to quantify all four clades simultaneously in vaginal samples
have shown associations between specific clades of G. vaginalis and BV in a study of 60 women
in the United States with chronic vaginal symptoms [9]. It has not yet been determined
whether these classifications are consistent with each other or whether clinically significant
phenotypic characteristics, such as sialidase activity [10] and biofilm formation [11, 12] are dif-
ferentially distributed among subgroups.
Sialidase activity is an important virulence factor associated with mucin degradation in BV
and aerobic vaginitis [13], contributing to adverse pregnancy outcomes [10]. Although this
activity is commonly detected in G. vaginalis, the trait is not common to all isolates, including
the type strain (ATCC 14018), and expression levels are highly variable among sialidase posi-
tive isolates [14]. Although some recent studies have investigated the presence of a putative sia-
lidase gene in relation to sialidase activity and ARDRA subgroups [5, 6], the relationship
between sialidase activity and more recent genotyping techniques has not been resolved. There-
fore, the objectives of the current study were: 1) to reconcile cpn60 UT-based molecular sub-
groups A-D with previously published clades 1–4, 2) to define cpn60 UT subgroups of 112
Gardnerella isolates and compare to classification based on ARDRA and clade-specific real-
time PCR assays and 3) to determine sialidase gene presence and activity in all 112 isolates, in
order to clarify distribution of this virulence factor across G. vaginalis subgroups.
Methods
Bacterial cultures and DNA extraction
The type strain of G. vaginalis (ATCC 14018) was obtained from the American Type Culture
Collection. All other isolates were obtained from previous studies of women from Kenya, Can-
ada and Belgium, as previously described [5, 8, 15]. Freezer stocks in 4% (w/v) skim milk or
NYC medium (ATCC broth #1685) with 10% glycerol (v/v) were revived on Columbia 5%
sheep’s blood agar (CBA; BD Biosciences, Mississauga, ON) and incubated anaerobically at
37°C using GasPak EZ sachets (BD Biosciences, Mississauga, ON) in sealed jars for 48–72h.
After two passages, isolates were harvested with a sterile swab into 2 ml sterile saline (0.85%
NaCl, pH 7.4) until turbidity was equivalent to McFarland standard 4. Turbidity was also
assessed quantitatively by measuring optical density of 100 μl harvested cultures in duplicate
wells of optically clear 96-well plates at 595 nm in a Vmax microplate reader (Molecular
Devices, Inc., Sunnyvale, CA). DNA was isolated from 100 μl of harvested culture by resus-
pending in a 5% solution of Chelex (Bio-Rad Inc., Mississauga, ON), followed by incubation at
60°C for 30 min, 100°C for 8 min, and supernatant used for all described PCR assays.
Determination of cpn60 subgroup and phylogenetic analysis
cpn60 subgroup (A, B, C or D) for all isolates included in this study was determined by Sanger
sequencing as previously described [8]. Phylogenetic comparison was carried out including
cpn60 universal target sequences extracted from the cpn60 database, cpnDB (www.cpndb.ca)
[16], as well as all available whole genome sequences in the Integrated Microbial Genomes
Sialidase inG. vaginalis Subgroups
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Expert Review (IMG/ER) database [17]. Full-length 16S rRNA gene sequences were available
for 18 of the 36 whole genome sequences in GenBank [18]. Neighbour-joining phylogenetic
trees for cpn60 and 16S rRNA gene sequences were created based on ClustalW aligned
sequences in MEGA v6 software, with bootstrap calculations based on 100 replicates. For
whole genome sequences, Pairwise Average Nucleotide Identity values using the MUMmer
algorithm and Tetranucleotide correlations were calculated within and between subgroups
using JSpecies [19]. Density plots were created using regular ggplot2 functions in R [20].
Amplified ribosomal DNA restriction analysis (ARDRA)
Amplification of the 16S rRNA gene, digestion of amplicon using TaqI restriction enzyme and
electrophoresis were carried out as described previously [8], based on techniques previously
used to define genotypes of G. vaginalis [4, 5]. Primer sequences are provided in S1 Table.
Real-time PCR to detectG. vaginalis subgroups
All isolates were assessed using SYBR Green and hydrolysis probe assays that were previously
designed to detect G. vaginalis subgroups in vaginal samples based on available whole genome
sequences defining clades 1 to 4 [9]. In this study, these primer/probe sets were used to assess
isolates by real-time PCR. Reactions were carried out in a CFX96 thermal cycler (Bio-Rad Inc.,
Mississauga, ON), using previously described reaction mixtures and PCR conditions [9]. Iso-
lates were defined as positive when the average fluorescence value (relative fluorescence units
or RFU) of the last 10 cycles of the amplification reaction, minus the standard deviation, was
greater than 800 RFU. Primer and probe sequences are provided in S1 Table.
Detection of sialidase gene presence
Presence of the putative sialidase A gene was assessed using previously published primer sets
(S1 Table). For conventional PCR, primers Sia1-F and -R were applied as previously described
[6]. For real-time PCR using SYBR Green, primers GVSI-F and -R were applied as previously
described [5]. Positive isolates were defined as described above. Differences in sialidase gene
presence were evaluated by Fisher's exact test in R [20].
Quantification of sialidase activity
Initially, a qualitative filter paper spot test was applied to detect sialidase enzyme activity of G.
vaginalis isolates, as previously described [8]. Subsequently, a more sensitive assay using quan-
titative fluorometry was applied [14]. The fluorogenic substrate for both assays was 2'-
(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid sodium salt hydrate (Sigma-Aldrich
Canada, Oakville, ON) dissolved in water (0.015% w/v) and aliquots stored at -20°C. Prior to
the assay, aliquots of substrate were thawed and 9 parts diluted with 1 part 1 M sodium acetate
(pH 5.8) and 10 μl of the reaction mixture was applied to filter paper circles. Cells harvested
from blood plates as described above (10 μl of McFarland standard 4 in saline) were added to
each circle and incubated at 37°C for 30 min in the dark. Sialidase activity was determined by
visualizing filter paper under UV light. For quantitative assays, 100 μl of substrate was com-
bined with 50 μl culture harvested from plates as described above into duplicate wells of a black
polystyrene flat bottom microplate (Whatman Inc., Clifton, NJ), prior to measuring RFU over
time in a FLx800 fluorometer (BioTek Inc., Winooski, VT). Readings were taken every 2 min.
after 6 seconds of shaking at 30°C over a 30 min. period. The rate of substrate conversion in
positive isolates was expressed as the increase in RFU over time, adjusted for cell concentration
as measured using McFarland standards and OD595 as described above. Differences in sialidase
Sialidase inG. vaginalis Subgroups
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activity across subgroups were evaluated by non-parametric Kruskal-Wallis and MannWhit-
ney U tests in SPSS (IBM Inc., Chicago, Illinois).
Results
Reconciling cpn60 UT subgroups with other published subgroups
In order to determine whether our previously published subgroups (A-D) correspond to previ-
ously published clades (1–4), we compared cpn60 UT sequences for 112 G. vaginalis isolates
from three continents with cpn60 UT sequences extracted from previously published whole
genome sequences (Fig 1). All new isolates and previously published genomes fall into four
cpn60 subgroups [8], including 17 isolates defined as belonging to clades 1–4 [7]. These results
indicate that similar phylogenetic resolution can be achieved using a partial single gene
sequence (552 bp), compared to using 473 full-length gene sequences common to all 17
genomes. cpn60 subgroup A corresponds to clade 4, subgroup B to clade 2, subgroup C to
clade 1, and subgroup D to clade 3.
Comparisons of pairwise similarity distributions of cpn60 UT sequences for all available G.
vaginalis isolates results in a bimodal distribution of inter- and intra-subgroup similarity (Fig
2A), confirming that isolates in each subgroup are phylogenetically distinct from isolates in
other subgroups. Interestingly, the lowest values in the intra-subgroup distribution correspond
to comparisons between the most phylogenetically distant branch of subgroup A (NR010 and
JCP8481A/B) and other subgroup A isolates (Fig 2A). Pairwise Average Nucleotide Identity
using MUMmer (Fig 2B) and tetranucleotide values (Fig 2C) calculated for 40 whole genome
sequences provide additional support for separate species within G. vaginalis, that cannot be
reliably distinguished using 1408 bp of the 16S rRNA gene (Fig 2D).
Evaluation of cpn60 UT typing in relation to other published typing
schemes
In order to evaluate performance of G. vaginalis subgroup typing using the cpn60 UT, we also
performed previously published molecular typing assays on all 112 isolates in this study. First,
we conducted genotyping of all isolates by amplified ribosomal DNA restriction analysis
(ARDRA) based on amplification of 16S rRNA gene sequences and digestion of the resulting
products with TaqI (Fig 3). All isolates fell into two ARDRA genotypes, with all cpn60 sub-
group A isolates (36/36) belonging to ARDRA genotype 1 (characterized by band sizes of 188,
196, 215, 316 and 471 bp), while all subgroup C isolates (35/35) belonged to ARDRA genotype
2 (characterized by band sized of 188, 196, 215, 360 and 471 bp) (Table 1, Fig 3). Subgroup B
and D isolates had both ARDRA genotypes, with 24/33 and 5/8 isolates with genotype 1 and 9/
33 and 3/8 isolates with genotype 2 in subgroups B and D, respectively. Therefore, each
ARDRA genotype observed in this study corresponded to three cpn60 subgroups (ARDRA
genotype 1 with subgroups A/B/D, and ARDRA genotype 2 with subgroups B/C/D). A third,
previously reported ARDRA genotype [4] was not detected in any isolate.
We also compared cpn60 UT subgroups to recently published clade-targeted real-time PCR
assays intended to differentiate G. vaginalis clades 1–4 in vaginal samples [9]. These assays
were based on subgroup-specific sequences derived from whole genome sequence analysis.
Our analysis shows that these assays were specific in all cases, since no assay designed to detect
one subgroup detected an isolate belonging to a different subgroup (Table 1, S1 Fig). All iso-
lates defined as cpn60 subgroup C were detected using the assays designed to detect them.
However, sensitivity was limited since several subgroup B and D isolates, as well as a single sub-
group A isolate (NR010), were negative in all assays (Table 1, S1 Fig). These findings were
Sialidase inG. vaginalis Subgroups
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Fig 1. Phylogenetic relationships ofG. vaginalis study isolates. Neighbour-joining phylogenetic tree of
nucleotide sequences (alignment length = 552 bp) of 68 cpn60 sequences representing 112 isolates and 36
other isolates for which cpn60 sequence was available from published genomes, using ClustalW and 100
bootstrap replicates in MEGA v6. cpn60 sequences were collapsed to 68 unique branches using blastclust
(100% identical over 100% length). Representative sequences from study isolates are in black text, while
sequences extracted from published genomes are shown in red. For each branch, genomes and isolates with
identical cpn60 sequences are shown as adjacent boxes with colour based on origin (grey = published
genomes, blue = Canada, red = Belgium, black = Kenya).
doi:10.1371/journal.pone.0146510.g001
Sialidase inG. vaginalis Subgroups
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confirmed by repeating real-time PCR assays using duplicate cultures, indicating that sub-
group-specific sequences identified for real-time PCR assay development were not found in all
isolates. Further work will be required to improve sensitivity of these assays.
Fig 2. Intra- and inter-subgroup relationships based on cpn60 and whole genome sequences. Density plots of pairwise comparisons within and
between cpn60 subgroups. A) Plot based on 2,278 comparisons with 68 aligned cpn60 universal target sequences (552 bp). The long tail of the intra-
subgroup distribution is explained by low identity of outliers NR010 and JCP8481A with the rest of subgroup A. B) Plot based on ANIm (average nucleotide
identity using MUMmer) including 780 comparisons with 40 whole genome sequences. Tail is due to low identity of JCP8481A/B with the rest of subgroup A.
C) Plot based on inter-strain correlation coefficient of tetranucleotide signature frequencies (780 comparisons, 40 genomes), with correlation values >0.99
between strains from the same cpn60 subgroup. Small peak at ~0.98 indicates comparisons between JCP8481A/B and other subgroup A genomes. D) Plot
based on 16S rRNA gene sequences (231 comparisons with 22 sequences of 1408bp), showing overlap of inter- and intra-subgroup percent identity
comparisons for this gene.
doi:10.1371/journal.pone.0146510.g002
Fig 3. Amplified ribosomal DNA restriction genotyping analysis ofG. vaginalis isolates. A) Model of TaqI (T^CAG) restriction sites in 16S rRNA PCR
products of subgroup A (409–05) and subgroup C (ATCC14019), B) Sizes of fragments associated with each ARDRA genotype, C) ARDRA profiles for
selectedG. vaginalis isolates, showing consistent profiles for subgroups A and C and inconsistent profiles for subgroup B. Lanes containing genotype 1
profiles are un-shaded; lanes containing genotype 2 profiles are highlighted in red.
doi:10.1371/journal.pone.0146510.g003
Sialidase inG. vaginalis Subgroups
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Sialidase gene presence and activity inG. vaginalis subgroups
In order to detect the presence of the gene for sialidase activity in our isolates, we applied two
previously published assays for detecting the putative sialidase A gene of ATCC 14019 (Gen-
bank Protein Accession YP_003985295) [5, 6]. All subgroup B, C and D isolates were sialidase
gene positive using both assays, and all but one subgroup A isolate (NR010) was sialidase gene
negative (Table 1, Fig 4A). These findings were confirmed by repeating assays using duplicate
cultures. Presence/absence of the putative sialidase gene across groups was significantly differ-
ent by Fisher’s exact test (p<0.0001).
Surprisingly, gene presence was not predictive of actual sialidase activity using both a quali-
tative (positive/negative) filter spot assay and highly sensitive quantitative assay based on a
fluorescent substrate (Fig 4 and S2 Fig). All subgroup B isolates were sialidase gene positive
and activity positive (Table 1, Fig 4). In contrast, all subgroup C isolates were sialidase gene
positive but only three isolates, all from Belgium, were sialidase activity positive (Table 1,
Table 1. Summary of molecular and phenotypic characteristics for 112 isolates ofG. vaginalis.
cpn60 subgroup
A (36) B (33) C (35) D (8)
Country of origin
Canada (40) 12 (30%) 11 (28%) 16 (40%) 1 (3%)
Belgium (18) 6 (33%) 6 (33%) 6 (33%) —
Kenya (54) 18 (33%) 16 (27%) 13 (24%) 7 (13%)
ARDRA1 Pattern
Genotype 1 36 (100%) 24 (73%) — 5 (63%)
Genotype 2 — 9 (17%) 35 (100%) 3 (37%)
Subgroup real-time PCR2 (hydrolysis probes)
Subgroup A 35 (97%) — — —
Subgroup B — 23 (70%) — —
Subgroup C — — 35 (100%) —
Subgroup D — — — 6 (75%)
No assay positive 1 (3%) 10 (30%) — 2 (25%)
Subgroup real-time PCR2 (SYBR green)
Subgroup A 30 (83%) — — —
Subgroup B — 20 (61%) — —
Subgroup C — — 35 (100%) —
Subgroup D — — — 8 (100%)
No assay positive 6 (17%) 13 (39%) — —
Sialidase gene presence3,*
Conventional PCR (Sia-F/R) 1 (3%) 33 (100%) 35 (100%) 8 (100%)
SYBR green (GVSI-F/R) 1 (3%) 33 (100%) 35 (100%) 8 (100%)
Sialidase activity4,*
Filter spot assay — 33 (100%) 3 (9%) —
Quantitative ﬂuorometry — 33 (100%) 3 (9%) —
1Ampliﬁed ribosomal DNA restriction analysis
2Subgroup-targeted real-time PCR
3PCR assays targeting the putative sialidase A
4Fluorescence assays using 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid to detect sialidase activity.
*Differences across G. vaginalis subgroups are statistically signiﬁcant by Fisher’s exact test (p<0.0001).
doi:10.1371/journal.pone.0146510.t001
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Fig 4). This finding was confirmed using duplicate cultures. All subgroup A and D isolates
were sialidase activity negative, despite detection of the sialidase gene in one subgroup A isolate
(NR010) and in all subgroup D isolates. The difference in sialidase activity (positive/negative)
across G. vaginalis subgroups was statistically significant by Fisher’s exact test (p<0.0001,
Table 1). When quantitative values for sialidase activity among subgroups were compared, a
significant difference was detected by non-parametric Kruskal-Wallis test (p<0.001). Subse-
quent pairwise comparisons showed that subgroup B had significantly higher activity than
other subgroups (MannWhitney U test, p<0.001)(Fig 4). Complete results for all 112 Gardner-
ella isolates described in this study are provided in S2 Table.
Discussion
Gardnerella vaginalis was first described in 1953 [21], and soon after described as the causative
agent of a new kind of vaginitis (Haemophilus vaginalis vaginitis) [22], now known as bacterial
vaginosis (BV). Despite decades of research, the specific etiology of BV and the role of Gardner-
ella in its clinical and subclinical manifestations remain controversial and poorly defined [2,
23]. Despite well-known phenotypic diversity [3], the possibility that G. vaginalismay actually
consist of several species with distinct roles in BV pathogenesis has only recently been investi-
gated [5, 7, 8]. Studies based on 16S rRNA variable-region targeted sequencing have known
biases against detecting Gardnerella at all [24, 25], much less resolving subgroups, although
one early deep sequencing study did distinguish four G. vaginalis subgroups based on a single
nucleotide difference in variable region 6 of the 16S rRNA gene [26]. Previous studies based on
TaqI restriction digest of 16S rRNA PCR products indicated the presence of at least three geno-
types [5, 7]. In this study, ARDRA pattern was consistent within all isolates in subgroup A
(ARDRA genotype 2) and C (ARDRA genotype 1), however subgroup B and D isolates had
Fig 4. Detection of sialidase gene and sialidase activity inGardnerella isolates. A) Quantitative
fluorometry of adjusted sialidase activity (rate of increase in fluorescence adjusted for optical density of
culture) confirms that all subgroup B isolates and 3/36 subgroup C isolates are sialidase positive, and all
subgroup A and D isolates are sialidase negative. This difference is statistically significant by non-parametric
Kruskal-Wallis test (p<0.001), and significant pairwise differences by MannWhitney U test (p<0.001) are
indicated with an asterisk. Phenotypic results are not concordant with PCR detection of the putative sialidase
gene, which is also significantly different across subgroups by Fisher’s exact test (p<0.0001). B) Sialidase
activity as measured by the filter spot assay, showing that only subgroup B isolates are sialidase positive.
Sialidase positive control is strain W11 and negative control is ATCC 14018.
doi:10.1371/journal.pone.0146510.g004
Sialidase inG. vaginalis Subgroups
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either ARDRA genotype. ARDRA genotype 3 was not observed in this study or in another
recent study of a smaller number of isolates [6]. In contrast, cpn60 sequence clearly distin-
guishes four G. vaginalis subgroups [25, 27–30], corresponding exactly to whole genome-based
analyses. This correspondence between cpn60 sequence and whole genome analyses has previ-
ously been shown for clostridia and Enterococcus [31, 32].
Bimodal distribution of pairwise ANIm values based on 40 whole genome sequences is consis-
tent with the suggested bacterial species level cut-off of 95–96% [19], corroborated by bootstrap
values [33] and high correlation of tetranucleotide signature frequencies within cpn60 subgroups
[19]. Although molecular criteria for designation ofG. vaginalis subgroups as separate species
have arguably been met, identification of additional phenotypic properties that consistently
resolve these subgroups is required before a formal proposal of reclassification can be made.
The strong correspondence between cpn60 subgroups and quantitative PCR results using
recently described assays based on subgroup-specific genes in whole genome sequences [9],
demonstrates the utility of both approaches. However, one subgroup A isolate and several sub-
group B and D isolates were negative by all primer sets. Since these assays were designed to
detect and quantify the four subgroups in vaginal samples simultaneously, our observations
indicate that some organisms within subgroups A, B and D would not be captured. For exam-
ple, NR010 shares a valid node with other subgroup A isolates, but differed from all other sub-
group A isolates since it was not detected by any subgroup-specific real-time PCR assay, and
was positive for the putative sialidase gene. It is only 88% similar to other subgroup A isolates
(the trailing left-hand tail on the intra-subgroup density curve), and also 88% identical to the
other outliers, JCP8481A and JCP8481B [14]. If confirmed in other isolates, this observation
indicates that NR010 and JCP8481A/B may represent two additional molecular subgroups of
Gardnerella in addition to the four that have already been described.
We have previously shown that subgroup B and C isolates, but no subgroup A and only some
subgroup D isolates, were positive for the putative sialidase gene [8]. In this study, we show that
this gene is detectable by PCR in all subgroup B, C and D isolates, and in one subgroup A isolate.
Our initial investigations revealed that only subgroup B isolates from Kenyan and Canadian sam-
ples were sialidase activity positive using the qualitative filter spot test. In a recent study where
sialidase activity was determined quantitatively [14], all subgroup B isolates and a single sub-
group C isolate were sialidase positive. In this study, all subgroup B isolates and three subgroup C
isolates were sialidase positive. The greater sensitivity of the quantitative assay allows us to con-
clude that most subgroup C isolates and all subgroup A and D isolates are sialidase activity nega-
tive and not weakly positive, despite presence of the putative sialidase gene.
Sialidase activity in G. vaginalis was first described in 1984 [34], however an explicit link
between the translated product of the putative gene sequence targeted by PCR assays used in
this study and actual enzymatic activity has yet to be confirmed for this organism. Although
one previous study did report that all sialidase gene positive strains were also sialidase activity
positive [5], this finding was not corroborated by the present study. A lack of sialidase activity
in isolates containing the putative gene could be explained by the presence of an alternative
gene encoding this activity or other factors abrogating gene expression. Differential sialidase
production by G. vaginalis subgroups has direct clinical significance since detection of sialidase
activity in vaginal fluid is currently used as a commercial diagnostic for BV [35]. Sialidase and
other mucolytic enzymatic activities in vaginal fluid are likely detrimental to the protective
mucous layer and have been proposed to play a role in recurrent BV and pre-term birth [1].
Determination of whether G. vaginalis subgroups are also ecologically distinct (i.e. occupy dif-
ferent niches in the female reproductive tract), and thus differentially associated with clinical
status will require further epidemiological investigations where G. vaginalis subgroup preva-
lence and abundance can be observed in the context of the entire microbiome [30]. Phenotypic
Sialidase inG. vaginalis Subgroups
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properties such as sialidase activity could result in G. vaginalis having a direct effect on the
overall composition of the community, leading to characteristic associations of G. vaginalis
subgroups with other particular vaginal bacterial species or consortia. For example, structured
polymicrobial biofilms containing primarily Gardnerella have been extensively observed in
women with persistent BV [12], and sialidase activity has been associated with biofilm forma-
tion [5, 36].
In conclusion, our findings have confirmed previous suggestions that new species designa-
tions are warranted for better resolution of G. vaginalis [7, 8]. The cpn60 universal target
sequence offers a powerful alternative to existing methods for differentiating G. vaginalis sub-
groups in cultured isolates and deep sequencing libraries [30]. Ongoing and future studies are
aimed at elucidating the clinical significance of sialidase activity in G. vaginalis subgroups.
Supporting Information
S1 Fig. Quantitative PCR using two sets of assays to detect cpn60 subgroup designations
A-D. Results for hydrolysis probe assays are shown on left and results for SYBR green assays
are shown on right. Final relative fluorescence units (RFU) were calculated as the mean RFU of
the final ten PCR cycles minus the standard deviation of the mean. Values greater than 800
were considered positive.
(PDF)
S2 Fig. Sialidase activity detection. Detection of sialidase activity by cleavage of fluorescent
substrate bound to sialic acid, using a filter spot assay (left) and quantitative fluorometry
(right). Note wide variation in rate of substrate hydrolysis and comparability between quantita-
tive and qualitative measures of identical isolates.
(PDF)
S1 Table. Primers and probes used in this study.
(PDF)
S2 Table. Phylogenetic and phenotypic characteristics of G. vaginalis isolates.
(PDF)
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